Carl Zeiss Meditec AG has won a patent infringement action before the District Court of Düsseldorf/Germany against VSY Biotechnology BV and its exclusive distribution partner Fritz Ruck Ophthalmologische Systeme GmbH.
At this year’s International Dental Show (IDS) in Cologne the Medical Technology Business Group of ZEISS is presenting EXTARO 300. It is poised to revolutionize and differentiate dental practices with Augmented Visualization, Digital Patient Communication and Single-Handed Operation.
Carl Zeiss Meditec announces the first ReLEx SMILE minimally-invasive laser eye surgery procedure has been performed in the United States with the ZEISS VisuMax femtosecond laser by Dr. Jon G. Dishler at the Dishler Laser Institute in Greenwood Village, Colorado.
Carl Zeiss Meditec continued its growth trend in the first quarter of 2016/17. Revenue increased by 6.6 percent (adjusted for currency effects: 5.4 percent), to €280.0m (prior year: €262.6m).
Carl Zeiss Meditec AG has brought financial year 2015/16 to a successful close with further growth: Revenue increased by 4.6 percent (adjusted for currency effects: 2.7 percent) to €1,088.4m.
ZEISS continues to set the pace in OCT innovation with Swept-Source OCT imaging that expands the potential for clinical researchers to open new frontiers of discovery in diseases affecting the retina.
The Medical Technology Business Group of ZEISS continues to strengthen its leadership team with the appointment of distinguished refractive surgeon and clinical professor of ophthalmology, Steven C. Schallhorn, MD as Chief Medical Officer for Global Ophthalmic Devices.
The Medical Technology Business Group of ZEISS has appointed Andrew Ihan Chang to lead its worldwide sales organization for the newly consolidated Strategic Business Unit Global Ophthalmic Devices.
The Medical Technology Business Group of ZEISS announces the introduction in the US of the VisuMax® Small Incision Lenticule Extraction (SMILE) procedure, the latest advancement in refractive surgery for the correction of myopia.
Carl Zeiss Meditec AG consolidates its ophthalmology activities in a single Strategic Business Unit; James V. Mazzo will head the new ophthalmology division.
ZEISS Cataract Suite markerless has shown in recent clinical studies to support surgeons in achieving excellent refractive outcomes.
New Swept-Source OCT technology platform from ZEISS empowers leading clinical experts around the world to expand discovery in clinical research for retina.
Medical technology company benefits from currency effects
At the 2015 Annual Meeting of the American Academy of Ophthalmology (AAO) in Las Vegas, ZEISS announces innovations for clinical excellence and practice performance in ophthalmology.
ZEISS introduces a new generation of high resolution Fundus cameras at the American Academy of Ophthalmology (AAO) in Las Vegas.
ZEISS is now adding INFRARED 800 to its OPMI® PENTERO® 800 surgical microscope for reconstructive surgery.
At the summer meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) in Barcelona, ZEISS is substantiating its unique portfolio of intraocular lenses with new study results.
The new PRIMUS 200 empowers small practices to offer their patients more comprehensive eye care, with a compact, easy-to-use OCT system that provides essential applications for retina, glaucoma and anterior segment.
At the summer meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) in Barcelona, scientific studies will be presented in which patient satisfaction with ZEISS trifocal intraocular lenses (IOL) was superior to that of comparable competitor products.
The ZEISS Retina Workplace helps eye care professionals get automated access to relevant clinical information at the point of decision.
Sets a New Standard for Efficient Visual Field Testing
IDS 2015 - ZEISS strengthens its portfolio for dentistry with a high-resolution camera and LED illumination.
Carl Zeiss Meditec AG grows in all business units
New Office in Dubai's Healthcare City
Oraya Therapy represents an attractive new treatment option for patients
Carl Zeiss Meditec posts slight revenue growth
ZEISS is offering cataract surgeons a greater diversity of products for enhanced safety and presenting a new product line for basic diagnostics
Innovations from ZEISS in key diagnostic and surgical areas at the 2014 American Academy of Ophthalmology (AAO) meeting in Chicago, including a comprehensive line of basic diagnostics / Additional distribution channel for cataract surgery products
Carl Zeiss Meditec in advanced negotiations with Abbott Medical Optics Inc. about US commercial collaboration
Doctors benefit from simple workflows, and patients from the excellent¹ visual outcomes
With the Essential Line, ZEISS offers its Customers an Expanded Diagnostic Portfolio
ZEISS presents the new IOLMaster 700 for better predictability and optimized workflows in cataract surgery